Delta-like ligand 3-targeted radioimmunotherapy for neuroendocrine prostate cancer. Korsen JA, Gutierrez JA, Tully KM, Carter LM, et al. Proc Natl Acad Sci U S A 2022;119:e2203820119.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Korsen JA, Gutierrez JA, Tully KM, Carter LM, et al. Delta-like ligand 3-targeted radioimmunotherapy for neuroendocrine prostate cancer. Proc Natl Acad Sci U S A 2022;119:e2203820119.
PMID: 35759660